Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2008 Feb;115(2):319-23.
doi: 10.1016/j.ophtha.2007.05.028. Epub 2007 Aug 13.

Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts

Affiliations
Comparative Study

Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts

Iryna A Falkenstein et al. Ophthalmology. 2008 Feb.

Abstract

Purpose: To compare the measurements of visual acuity (VA) results measured with Snellen and Early Treatment Diabetic Retinopathy Study (ETDRS) charts in eyes with and without age-related macular degeneration (AMD).

Design: Cross-sectional study.

Participants: One hundred four participants (190 eyes) selected from a university retina practice; 80 participants (142 eyes) had some degree of AMD.

Methods: Visual acuity was measured in each patient using standard procedure with both Snellen and ETDRS charts in random order. Statistical analysis of the results was performed.

Main outcome measures: Difference in VA measured by both charts in logarithm of minimal angle of resolution (logMAR) notations.

Results: Overall, the mean Snellen VA was 0.78 logMAR (= 20/120), and the mean ETDRS VA in the same eye was 0.54 logMAR (= 20/70; P<0.001). In the low vision group (<20/200), represented by patients with AMD, the average difference in number of lines was considerably larger than in the good vision range (>20/30). On average, 20/200 on Snellen was 20/95 on ETDRS (>3 lines difference), and 20/30 on Snellen was 20/25 on ETDRS (<1 line difference).

Conclusion: Our results show poor agreement between the Snellen and ETDRS charts, and it was more pronounced in the group with poor vision. The ETDRS measurements yielded better VA, particularly in participants with vision <20/200 (representing more advanced AMD patients). We suggest taking these findings into consideration when comparing outcomes in clinical practices (which typically measure VA using standard Snellen charts) with outcomes from clinical trials (which typically measure VA using ETDRS charts).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Visual acuity (VA) measurement differences between Snellen and Early Treatment Diabetic Retinopathy Study (ETDRS) charts. This figure is a Bland-Altman chart, which graphically displays VA discrepancy between the 2 charts. The x-axis displays mean VA value between Snellen and ETDRS - (Snellen + ETDRS)/2; the y-axis displays the difference between measurements by both charts (ETDRS - Snellen). All numerical values on x-and y-axes are logarithm of the minimum angle of resolution (logMAR) units. All points below the solid line reflect Snellen score worse than ETDRS score in the same person and vice versa.

References

    1. Gibson RA, Sanderson HF. Observer variation in ophthalmology. Br J Ophthalmol. 1980;64:457–60. - PMC - PubMed
    1. Wick B, Schor CM. A comparison of the Snellen chart and the S-chart for visual acuity assessment in amblyopia. J Am Optom Assoc. 1984;55:359–61. - PubMed
    1. Lovie-Kitchin JE. Validity and reliability of visual acuity measurements. Ophthalmic Physiol Opt. 1988;8:363–70. - PubMed
    1. Kniestedt C, Stamper RL. Visual acuity and its measurements. Ophthalmol Clin North Am. 2003;16:155–70. - PubMed
    1. Pandit JC. Testing acuity of vision in general practice: reaching recommended standard. BMJ. 1994;26(6966):1408. - PMC - PubMed

Publication types

MeSH terms